Next Fertility has a unit specialized in reproductive genetics. Our goal is to diagnose and prevent chromosomal abnormalities and genetic diseases present in both the parents and the embryo before implantation in the maternal uterus.
Thanks to advances in assisted reproduction and genetics, we can avoid repeated miscarriages, embryo implantation problems and avoid the presence of genetic diseases in the embryo and future baby.
What is it?
Embryonic genetic diagnosis (PGT) techniques are used in assisted reproduction to detect abnormalities in the genetic material of embryos. This is a complementary technique that can be applied during in vitro fertilisation (IVF).
In this way, we avoid transferring embryos with genetic or chromosomal alterations that imply a high probability of developing a genetic disease or that present little viability to continue its evolution in the maternal uterus.
What does it consist of?
It consists of doing a biopsy of the cells of the embryo before being transferred to the uterus and studying them in the genetic diagnostic laboratory in order to identify the embryos that are carriers of a certain genetic disease.
What does PGT allow?
- Improving embryo selection. We will have information about which embryos do not have alterations and therefore are more likely to give rise to a healthy child.
- To reduce the risk of miscarriage by preventing embryo transfer with a low probability of implantation.
- Reducing the costs and the number of treatments, since it will not be necessary to freeze and transfer embryos with genetic alterations, since we already know that they will not be viable.